blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2453926

EP2453926 - PEPTIDES WHOSE UPTAKE IN CELLS IS CONTROLLABLE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  08.07.2016
Database last updated on 30.10.2024
Most recent event   Tooltip08.07.2016Application deemed to be withdrawnpublished on 10.08.2016  [2016/32]
Applicant(s)For all designated states
The Regents of the University of California
1111 Franklin Street, 12th Floor
Oakland, CA 94607 / US
[N/P]
Former [2012/21]For all designated states
The Regents of the University of California
1111 Franklin Street, 12th Floor
Oakland, CA 94607 / US
Inventor(s)01 / TSIEN, Roger
2665 Idle Hour Lane
La Jolla California 92037 / US
02 / OLSON, Emilia
1416 Boylston Avenue Apt. 502
Seattle Washington 98122 / US
03 / JIANG, Tao
10637 Gingerwood Court
San Diego California 92130 / US
04 / NGUYEN, Quyen
14094 Rue Saint Raphael
Del Mar California 92014 / US
05 / WHITNEY, Mike
5171 Frink Avenue
San Diego California 92117 / US
 [2012/21]
Representative(s)Campbell, Patrick John Henry
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[2012/21]
Application number, filing date10800571.115.07.2010
WO2010US42188
Priority number, dateUS20090225872P15.07.2009         Original published format: US 225872 P
[2012/21]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2011008996
Date:20.01.2011
Language:EN
[2011/03]
Type: A2 Application without search report 
No.:EP2453926
Date:23.05.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 20.01.2011 takes the place of the publication of the European patent application.
[2012/21]
Search report(s)International search report - published on:KR26.05.2011
(Supplementary) European search report - dispatched on:EP15.07.2015
ClassificationIPC:C07K7/06, C07K7/08, G01N33/52, G01N33/68, A61K47/42, A61K49/00, A61K47/48
[2015/33]
CPC:
A61K49/0032 (EP,US); A61K47/64 (US); A61K47/595 (EP,US);
A61K47/60 (EP,US); A61K47/62 (EP,US); A61K47/6911 (EP,US);
A61K49/0056 (EP,US); A61P35/00 (EP); A61P9/00 (EP);
C07K7/06 (EP,US) (-)
Former IPC [2012/21]A61K49/14, G01N33/52, G01N33/68, C07K7/08, A61K38/10, A61P9/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/21]
TitleGerman:PEPTIDE MIT STEUERBARER ZELLULÄRER AUFNAHME[2012/21]
English:PEPTIDES WHOSE UPTAKE IN CELLS IS CONTROLLABLE[2012/21]
French:PEPTIDES DONT L ABSORPTION PAR LES CELLULES PEUT ÊTRE RÉGULÉE[2012/21]
Entry into regional phase14.02.2012National basic fee paid 
14.02.2012Search fee paid 
14.02.2012Designation fee(s) paid 
14.02.2012Examination fee paid 
Examination procedure14.02.2012Examination requested  [2012/21]
17.09.2012Amendment by applicant (claims and/or description)
11.02.2016Application deemed to be withdrawn, date of legal effect  [2016/32]
18.03.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2016/32]
Fees paidRenewal fee
25.07.2012Renewal fee patent year 03
29.07.2013Renewal fee patent year 04
28.07.2014Renewal fee patent year 05
27.07.2015Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2005042034  (UNIV CALIFORNIA [US], et al) [A] 1-15 * abstract *;
 [X]WO2006125134  (UNIV CALIFORNIA [US], et al) [X] 1-5,7-15 * abstract * * page 6, paragraph 18 - paragraph 19; table 1 * * page 38, paragraph 167 * * page 63, paragraph 224; examples 19,20,22,23,27,32 * * claims 21-27 *;
 [X]  - E.S. Olson, "Activatable Cell Penetrating Peptides for Imaging Protease Activity In Vivo", University of California, San Diego, (2008), pages FP-xvii,1 - 152, URL: https://escholarship.org/uc/item/3sc4h3n7#page-1, (20150703), XP002741765 [X] 1-15 * page 65 - page 133 *
 [X]  - OLSON EMILIA S ET AL, "In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer", INTEGRATIVE BIOLOGY, RSC PUBLISHING, (20090601), vol. 1, no. 5-6, ISSN 1093-4391, pages 382 - 393, XP009163754 [X] 1-5,7-10,12-15 * whole document, in particular page 388, left-hand column, paragraph 2 to page 389, left-hand column, paragraph 1; Fig.6 *

DOI:   http://dx.doi.org/10.1039/b904890a
 [X]  - JIANG T ET AL, "Tumor imaging by means of proteolytic activation of cell-penetrating peptides", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, (20041221), vol. 101, no. 51, doi:10.1073/PNAS.0408191101, ISSN 0027-8424, pages 17867 - 17872, XP002369426 [X] 1-5,7-10,12-15 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.0408191101
 [A]  - AGUILERA TODD A ET AL, "Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides", INTEGRATIVE BIOLOGY, ROYAL SOCIETY OF CHEMISTRY, UK, vol. 1, no. 5-6, doi:10.1039/B904878B, ISSN 1757-9694, (20090601), pages 371 - 381, (20090511), XP009163753 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1039/B904878B
International search[A]US5910300  (TOURNIER HERVE [FR], et al);
 [A]US2001021763  (HARRIS J MILTON [US]);
 [A]US2004009122  (KLAVENESS JO [NO], et al);
 [A]US2004241096  (BOGDANOV ALEXEI [US], et al);
 [A]US2005107583  (JIANG TAO [US], et al);
 [A]US2009004118  (NIE SHUMING [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.